|
97 |
Presentng a new direction for COVID-19 and cancer treatment
HOT
2024-03-12
2341
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2341 |
|
96 |
Adipo LABs’ practice of ‘humanity’ that transcends borders
HOT
2024-03-12
2284
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2284 |
|
94 |
AdipoLABs CEO Han Sung-ho visits the National Cemetery
HOT
2024-03-12
2121
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2121 |
|
93 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
HOT
2024-03-12
2015
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2015 |
|
92 |
“COVID-19 treatment needs a major shift to hyperthermia therapy.”
HOT
2024-03-12
2098
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2098 |
|
91 |
“Angola, no exception to the COVID-19 threat, recognizes the value of REMISSION 1℃”
HOT
2024-03-12
2113
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2113 |
|
90 |
'REMISSION 1℃’ to fight COVID-19 is exported worldwide
HOT
2024-03-12
2084
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2084 |
|
89 |
‘REMISSION 1℃’ expected to be a ‘game changer’ in COVID-19 treatment
HOT
2024-03-12
2170
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2170 |
|
88 |
Global COVID-19 Overcoming Collaboration Group ‘IVRA’ Launched, “Proposed Treatment Guide”
HOT
2024-03-12
2106
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2106 |
|
87 |
World's first joint collaboration to overcome COVID-19 treatment, IVRA is launched.
HOT
2024-03-12
2170
(주)아디포랩스
|
(주)아디포랩스 |
2024-03-12 |
2170 |
|
85 |
IVRA draws attention to presenting a new medical paradigm to overcome COVID-19
HOT
2024-02-21
2441
(주)아디포랩스
|
(주)아디포랩스 |
2024-02-21 |
2441 |
|
83 |
Establishment of IVRA with medical staff from 30 countries, “preparation of coronavirus treatment measures”
HOT
2024-02-21
2564
(주)아디포랩스
|
(주)아디포랩스 |
2024-02-21 |
2564 |